Search research articles
Contact Us
Filters
Showing results (51-60 of 420) with videos related to
Page
of 42
Sort By:
Current Oncology Reports
|
October 17, 2024
AML in the Elderly - When less may be more
Eric S Winer, Richard M Stone
American Journal of Hematology
|
January 3, 2023
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management
Shai Shimony, Maximilian Stahl, Richard M Stone
American Journal of Hematology
|
February 12, 2025
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management
Shai Shimony, Maximilian Stahl, Richard M Stone
Current Opinion in Hematology
|
December 30, 2021
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes
Shai Shimony, Richard M Stone, Maximilian Stahl
The New England Journal of Medicine
|
November 9, 2017
Midostaurin in FLT3-Mutated Acute Myeloid Leukemia
Richard M Stone, Richard A Larson, Hartmut Döhner
Leukemia Research
|
December 7, 2011
AKT1 induces caspase-mediated cleavage of the CDK inhibitor p27Kip1 during cell cycle progression in leukemia cells transformed by FLT3-ITD
Xinping Yang, Suiyang Liu, Surender Kharbanda, et al.
Expert Review of Hematology
|
November 19, 2010
FLT3 inhibitors in acute myeloid leukemia
Khaled el-Shami, Richard M Stone, B Douglas Smith
Seminars in Oncology
|
June 4, 2004
Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome
Richard M Stone, D Gary Gilliland, Amy D Klion
Cancer Cell
|
September 12, 2018
Location, Location, Location: Mutant NPM1c Cytoplasmic Localization Is Required to Maintain Stem Cell Genes in AML
Hannah J Uckelmann, Scott A Armstrong, Richard M Stone
Hematology. American Society of Hematology. Education Program
|
November 25, 2004
Acute myeloid leukemia
Richard M Stone, Margaret R O'Donnell, Mikkael A Sekeres
Page
of 42
Search research articles
Search
Showing results (51-60 of 420) with videos related to
Sort By:
Page
of 42
Current Oncology Reports
|
October 17, 2024
AML in the Elderly - When less may be more
Eric S Winer, Richard M Stone
American Journal of Hematology
|
January 3, 2023
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management
Shai Shimony, Maximilian Stahl, Richard M Stone
American Journal of Hematology
|
February 12, 2025
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management
Shai Shimony, Maximilian Stahl, Richard M Stone
Current Opinion in Hematology
|
December 30, 2021
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes
Shai Shimony, Richard M Stone, Maximilian Stahl
The New England Journal of Medicine
|
November 9, 2017
Midostaurin in FLT3-Mutated Acute Myeloid Leukemia
Richard M Stone, Richard A Larson, Hartmut Döhner
Leukemia Research
|
December 7, 2011
AKT1 induces caspase-mediated cleavage of the CDK inhibitor p27Kip1 during cell cycle progression in leukemia cells transformed by FLT3-ITD
Xinping Yang, Suiyang Liu, Surender Kharbanda, et al.
Expert Review of Hematology
|
November 19, 2010
FLT3 inhibitors in acute myeloid leukemia
Khaled el-Shami, Richard M Stone, B Douglas Smith
Seminars in Oncology
|
June 4, 2004
Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome
Richard M Stone, D Gary Gilliland, Amy D Klion
Cancer Cell
|
September 12, 2018
Location, Location, Location: Mutant NPM1c Cytoplasmic Localization Is Required to Maintain Stem Cell Genes in AML
Hannah J Uckelmann, Scott A Armstrong, Richard M Stone
Hematology. American Society of Hematology. Education Program
|
November 25, 2004
Acute myeloid leukemia
Richard M Stone, Margaret R O'Donnell, Mikkael A Sekeres
Page
of 42